TY - JOUR
T1 - Brain calcifications and PCDH12 variants
AU - Nicolas, Gaël
AU - Sanchez-Contreras, Monica
AU - Ramos, Eliana Marisa
AU - Lemos, Roberta R.
AU - Ferreira, Joana
AU - Moura, Denis
AU - Sobrido, Maria J.
AU - Richard, Anne Claire
AU - Lopez, Alma Rosa
AU - Legati, Andrea
AU - Deleuze, Jean François
AU - Boland, Anne
AU - Quenez, Olivier
AU - Krystkowiak, Pierre
AU - Favrole, Pascal
AU - Geschwind, Daniel H.
AU - Aran, Adi
AU - Segel, Reeval
AU - Levy-Lahad, Ephrat
AU - Dickson, Dennis W.
AU - Coppola, Giovanni
AU - Rademakers, Rosa
AU - De Oliveira, João R.M.
N1 - Publisher Copyright:
Copyright © 2017 The Author(s).
PY - 2017
Y1 - 2017
N2 - Objective: To assess the potential connection between PCDH12 and brain calcifications in a patient carrying a homozygous nonsense variant in PCDH12 and in adult patients with brain calcifications. Methods: We performed a CT scan in 1 child with a homozygous PCDH12 nonsense variant. We screened DNA samples from 53 patients with primary familial brain calcification (PFBC) and 26 patients with brain calcification of unknown cause (BCUC). Results: We identified brain calcifications in subcortical and perithalamic regions in the patient with a homozygous PCDH12 nonsense variant. The calcification pattern was different from what has been observed in PFBC and more similar to what is described in in utero infections. In patients with PFBC or BCUC, we found no protein-truncating variant and 3 rare (minor allele frequency <0.001) PCDH12 predicted damaging missense heterozygous variants in 3 unrelated patients, albeit with no segregation data available. Conclusions: Brain calcifications should be added to the phenotypic spectrum associated with PCDH12 biallelic loss of function, in the context of severe cerebral developmental abnormalities. A putative role for PCDH12 variants remains to be determined in PFBC.
AB - Objective: To assess the potential connection between PCDH12 and brain calcifications in a patient carrying a homozygous nonsense variant in PCDH12 and in adult patients with brain calcifications. Methods: We performed a CT scan in 1 child with a homozygous PCDH12 nonsense variant. We screened DNA samples from 53 patients with primary familial brain calcification (PFBC) and 26 patients with brain calcification of unknown cause (BCUC). Results: We identified brain calcifications in subcortical and perithalamic regions in the patient with a homozygous PCDH12 nonsense variant. The calcification pattern was different from what has been observed in PFBC and more similar to what is described in in utero infections. In patients with PFBC or BCUC, we found no protein-truncating variant and 3 rare (minor allele frequency <0.001) PCDH12 predicted damaging missense heterozygous variants in 3 unrelated patients, albeit with no segregation data available. Conclusions: Brain calcifications should be added to the phenotypic spectrum associated with PCDH12 biallelic loss of function, in the context of severe cerebral developmental abnormalities. A putative role for PCDH12 variants remains to be determined in PFBC.
UR - http://www.scopus.com/inward/record.url?scp=85041031796&partnerID=8YFLogxK
U2 - 10.1212/NXG.0000000000000166
DO - 10.1212/NXG.0000000000000166
M3 - Article
AN - SCOPUS:85041031796
SN - 2376-7839
VL - 3
JO - Neurology: Genetics
JF - Neurology: Genetics
IS - 4
ER -